Page last updated: 2024-10-30

losartan and Leukoma

losartan has been researched along with Leukoma in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Topical losartan decreased scar-producing stromal myofibroblasts after irregular PTK over a metal screen but early smoothing of irregularity would also likely be needed to significantly decrease corneal opacity."8.31Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits. ( Sampaio, LP; Santhiago, MR; Shiju, TM; Villabona-Martinez, V; Wilson, SE, 2023)
"Losartan is an inhibitor of transforming growth factor-β signaling."5.72Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. ( Ambrósio, R; Bandeira, F; Pereira-Souza, AL; Salomão, MQ; Souza Lima, A; Wilson, SE, 2022)
"Topical losartan decreased scar-producing stromal myofibroblasts after irregular PTK over a metal screen but early smoothing of irregularity would also likely be needed to significantly decrease corneal opacity."4.31Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits. ( Sampaio, LP; Santhiago, MR; Shiju, TM; Villabona-Martinez, V; Wilson, SE, 2023)
"Losartan is an inhibitor of transforming growth factor-β signaling."1.72Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. ( Ambrósio, R; Bandeira, F; Pereira-Souza, AL; Salomão, MQ; Souza Lima, A; Wilson, SE, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Pereira-Souza, AL1
Ambrósio, R1
Bandeira, F1
Salomão, MQ1
Souza Lima, A1
Wilson, SE2
Sampaio, LP1
Villabona-Martinez, V1
Shiju, TM1
Santhiago, MR1

Other Studies

2 other studies available for losartan and Leukoma

ArticleYear
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2022, Volume: 38, Issue:11

    Topics: Adult; Corneal Diseases; Corneal Opacity; Corneal Stroma; Female; Fibrosis; Humans; Keratomileusis,

2022
Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits.
    Translational vision science & technology, 2023, 09-01, Volume: 12, Issue:9

    Topics: Animals; Collagen Type IV; Corneal Opacity; Losartan; Myofibroblasts; Rabbits; Vimentin

2023